PAOG Releases Cannabis Drug Development Update
Sandusky, Ohio--(Newsfile Corp. - October 15, 2020) - PAO Group, Inc. (OTC Pink: PAOG) today published a progress update on the company's ongoing initiative to advance an investigational New Drug application (IND) with the Food and Drug Administration (FDA). PAOG anticipates entering into an agreement with a contract research organization (CRO) within the next two weeks. The CRO engagement will be a major breakthrough in advancing PAOG's RespRx treatment for Chronic Obstructive Pulmonary...
2020-10-15 9:10 AM EDT
PAOG Targets Spring Launch of Hemp Cultivar Facility
Sandusky, Ohio--(Newsfile Corp. - October 13, 2020) - PAO Group, Inc. (OTC Pink: PAOG) today confirmed an agreement with Puration, Inc. (OTC Pink: PURA) to build a proprietary hemp cultivar development facility on PURA's Farmersville, Texas branded site and announced an April 2021 target date for construction to be completed.PAOG recently acquired a hemp cultivation business from PURA and is now expanding upon that business to develop a proprietary hemp cultivar in conjunction with the...
2020-10-13 9:09 AM EDT
PAOG CEO Jim DiPrima Answers Questions About Cannabis Investigational New Drug Application Plans with FDA
Sandusky, Ohio--(Newsfile Corp. - October 2, 2020) - PAO Group, Inc. (OTC Pink: PAOG) today announced an interview of CEO Jim DiPrima on MoneyTV where Mr. DiPrima discusses recent news regarding PAOG's latest moves to engage a contract research organization (CRO) to advance an investigational New Drug application (IND) with the Food and Drug Administration (FDA).MoneyTV is the internationally syndicated television program all about money and what makes it happen, (http://www.moneytv.net),...
2020-10-02 10:01 AM EDT
PAOG Engages Saul Kaye, Founder of iCAN: Israel-Cannabis and CannaTech to Prepare RespRx for IND
Sandusky, Ohio--(Newsfile Corp. - October 1, 2020) - PAO Group, Inc. (OTC Pink: PAOG) today announced engaging Saul Kaye, the founder of iCAN (www.israel-cannabis.com) and CannaTech (www.canna-tech.co) to provide an independent review of PAOG's RespRx research for the treatment of Chronic Obstructive Pulmonary Disease (COPD), and to help prepare RespRx for engaging with a contract research organization (CRO) to advance an investigational New Drug application (IND) with the Food and Drug...
2020-10-01 10:08 AM EDT
PAOG Cannabis Pharmaceutical Research Initiative Gains New Traction
Sandusky, Ohio--(Newsfile Corp. - September 30, 2020) - PAO Group, Inc. (OTC Pink: PAOG) today indicated plans to reveal new information on the Company's initiative to expand its cannabis pharmaceutical treatment research beyond its current focus on Chronic Obstructive Pulmonary Disease (COPD).In a media interview scheduled for release on Friday, October 2nd, PAOG Jim DiPrima will highlight a new pharmaceutical cannabis research expert resource engaged by the company to bring new industry...
2020-09-30 9:28 AM EDT
PAOG Expands Cannabis Pharma Treatment Research
Sandusky, Ohio--(Newsfile Corp. - September 24, 2020) - PAO Group, Inc. (OTC Pink: PAOG) today announced the company will expand its cannabis pharmaceutical treatment research beyond its current focus on Chronic Obstructive Pulmonary Disease (COPD).On July 30, 2020, PAOG acquired RespRx from Kali-Extracts, Inc. (OTC Pink: KALY). RespRx is a cannabis treatment under development for COPD derived from a patented cannabis extraction method - U.S. Patent No. 9,199,960 entitled "METHOD AND...
2020-09-24 12:10 PM EDT
PAOG Target, CBD Pharma Development, In Puerto Rico Could Get Boost From COVID-19
Sandusky, Ohio--(Newsfile Corp. - September 17, 2020) - PAO Group, Inc. (OTC Pink: PAOG) today highlighted recent increased interest in the resurgence of industry wide pharmaceutical research and manufacturing in Puerto Rico.Pharmaceutical ResearchTo view an enhanced version of this graphic, please visit:
2020-09-17 11:08 AM EDT
PAOG Announces Agreement to Build Pharmaceutical Hemp Cultivar Facility on PURA Farmersville Site
Sandusky, Ohio--(Newsfile Corp. - September 16, 2020) - PAO Group, Inc. (OTC Pink: PAOG) today announced an agreement with Puration, Inc. (OTC Pink: PURA) to build a proprietary hemp cultivar development facility on PURA's Farmersville, Texas branded site.PAOG recently acquired a hemp cultivation business from PURA and is now expanding upon that business to develop a proprietary hemp cultivar in conjunction with the company's overall pharmaceutical focus.PAOG is developing a hemp derived...
2020-09-16 9:13 AM EDT
PAOG Advances RespRx Research Into International CBD Pharma Research Arena
Sandusky, Ohio--(Newsfile Corp. - September 15, 2020) - PAO Group, Inc. (OTC Pink: PAOG) today announced an international research initiative to advance its hemp derived cannabidiol (CBD) pharmaceutical treatment for Chronic Obstructive Pulmonary Disease (COPD).Cannabidiol CBD clear oil capsules and full spectrum Hemp paste on wooden tableTo view an enhanced version
2020-09-15 3:05 PM EDT
PAOG Goes Global with CBD Pharmaceutical Research to Target $5.8 Billion Market
Sandusky, Ohio--(Newsfile Corp. - September 15, 2020) - PAO Group, Inc. (OTC Pink: PAOG) announces a multifold, international research initiative to advance its hemp derived cannabidiol (CBD) pharmaceutical treatment for Chronic Obstructive Pulmonary Disease (COPD).The COPD treatment, RespRx, is derived from a patented cannabis extraction method - U.S. Patent No. 9,199,960 entitled "METHOD AND APPARATUS FOR PROCESSING HERBACEOUS PLANT MATERIALS INCLUDING THE CANNABIS PLANT". In an initial...
2020-09-15 9:44 AM EDT
PAOG New Updates Toward Penetrating $5.8B Cannabis Pharmaceutical Market Coming This Friday
Sandusky, Ohio--(Newsfile Corp. - September 14, 2020) - PAO Group, Inc. (OTC Pink: PAOG) today announced an interview of CEO James C. DiPrima on MoneyTV with Donald Baillargeon scheduled for release this Friday, September 18, 2020. DiPrima will discuss the company's latest CBD bio pharma developments in addition to fielding questions on the recently Goldman Small Cap Analyst Research Update that includes target pricing.Grand View Research projects that the cannabis pharmaceutical market will...
2020-09-14 2:17 PM EDT
PAOG Rated Bullish And Given PPS Target In Updated Analyst Report Published Today
Sandusky, Ohio--(Newsfile Corp. - September 8, 2020) - PAO Group, Inc. (OTC Pink: PAOG) today announced Goldman Small Cap Research has published an analyst research report update. PAOG has recently entered the cannabis biopharmaceutical sector through two recent acquisitions. The company acquired a cannabis cultivation business from Puration, Inc. (PURA). From Kali-Extracts (KALY), PAOG acquired a proprietary CBD extract derived from a patented extraction process and formulated for the...
2020-09-08 10:37 AM EDT
PAOG Announces Goldman Small Cap Research Update Scheduled Next Week
Sandusky, Ohio--(Newsfile Corp. - September 2, 2020) - PAO Group, Inc. (OTC Pink: PAOG) today announced an analyst research report update form Goldman Small Cap Research scheduled to be published next week on Tuesday, September 8, 2020.The original Goldman Small Cap Research Update can be reviewed at:Under The Radar CBD Pharma Player Could Offer Major UpsidePAOG recently executed two acquisitions as part of an overall business revitalization strategy bringing the company into the cannabis...
2020-09-02 1:20 PM EDT
PAOG Completes Compliance Updates In Conjunction With Cannabis Biopharma Revitalization Initiative
Sandusky, Ohio--(Newsfile Corp. - August 27, 2020) - PAO Group, Inc. (OTC Pink: PAOG) today announced having published all required filings necessary to meet the OTC Markets "Current Information" reporting standard. Yesterday, the company published the final compliance requirement, a legal opinion, following the publications of its Q1 2020 and Q2 2020 report earlier this week and the 2019 annual report published late last week. The company anticipates the "Current Information" status to soon...
2020-08-27 9:14 AM EDT
PAOG Files Q1 2020 and Q2 2020 Reports Moving Closer To Current Info Status
Sandusky, Ohio--(Newsfile Corp. - August 25, 2020) - PAO Group, Inc. (OTC Pink: PAOG) today announced filing its Q1 2020 and Q2 2020 reports after yesterday announcing the filing of its 2019 annual report.PAOG recently executed two acquisitions as part of an overall business revitalization strategy bringing the company into the CBD biopharmaceutical sector. The revitalization strategy includes updating the company's financial statements to make the company compliant with the OTC Markets'...
2020-08-25 9:47 AM EDT
PAOG Files 2019 Annual Report In Conjunction With CBD Biopharma Revitalization
Sandusky, Ohio--(Newsfile Corp. - August 24, 2020) - PAO Group, Inc. (OTC Pink: PAOG) today announced filing its 2019 annual report and expects to soon have all its public disclosures in compliance with OTC Markets "Current Information" reporting standard. PAOG recently executed two acquisitions as part of an overall business revitalization strategy bringing the company into the CBD biopharmaceutical sector. The revitalization strategy includes updating the company's financial statements to...
2020-08-24 1:52 PM EDT
PAOG Financial Report Compliance Expected Soon Following Recent CBD Biotech Acquisitions
Sandusky, Ohio--(Newsfile Corp. - August 21, 2020) - PAO Group, Inc. (OTC Pink: PAOG) confirmed today that the company expects to soon have its public disclosures in compliance with OTC Markets "Current Information" reporting standard. The efforts underway are expected to see the company back in compliance no later than by the end of this month.PAOG recently executed two acquisitions as part of an overall business revitalization strategy bringing the company into the CBD biopharmaceutical...
2020-08-21 12:04 PM EDT
PAOG Explores Cannabis Respiratory Research Partnership in Israel
Sandusky, Ohio--(Newsfile Corp. - August 14, 2020) - PAO Group, Inc. (OTC Pink: PAOG) today announced the company is aggressively pursuing international research partnerships to advance its cannabis respiratory treatment development.The company recently revealed research partnership developments in Puerto Rico where Congresswoman Jenniffer González Colón and Florida Senator Marco Rubio recently introduced legislation to position Puerto Rico as a global production center of medical equipment...
2020-08-14 11:44 AM EDT
PAOG Confirms Analyst Report Update Expected After Coming Financial Report
Sandusky, Ohio--(Newsfile Corp. - August 14, 2020) - PAO Group, Inc. (OTC Pink: PAOG) after earlier today announcing the publication of an initial Goldman Small Cap Research Analyst Report, management now confirms a prompt second report coming from Goldman following PAOG's soon to be filed up-to-date financial reports.PAOG recently executed two acquisitions as part of an overall business revitalization strategy bringing the company into the cannabis biopharmaceutical sector. The...
2020-08-14 9:31 AM EDT
PAOG Announces Goldman Small Cap Research Analyst Report
Sandusky, Ohio--(Newsfile Corp. - August 13, 2020) - PAO Group, Inc. (OTC Pink: PAOG) today announced Goldman Small Cap Research has published an initial analyst report covering PAOG's outlook following two recent acquisitions moving the company into the cannabis biopharma market sector. The report highlights that recent acquisitions have repositioned PAOG for growth in a sector with market cap valuations as high as $100 million.
2020-08-13 11:36 AM EDT